Systemic therapy with or without transcatheter intra-arterial therapies for unresectable hepatocellular carcinoma: a real-world, multi-center study

BACKGROUND: Systemic therapy is the standard care of unresectable hepatocellular carcinoma (uHCC), while transcatheter intra-arterial therapies (TRITs) were also widely applied to uHCC patients in Chinese practice. However, the benefit of additional TRIT in these patients is unclear. This study inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Yangxun, Zhu, Xiaodong, Liu, Jianwei, Zhong, Jianhong, Zhang, Wei, Shen, Shunli, Jin, Renan, Liu, Hongzhi, Ye, Feng, Hu, Kuan, Xu, Da, Zhang, Yu, Chen, Zhong, Xing, Baocai, Zhou, Ledu, Chen, Yongjun, Zeng, Yongyi, Liang, Xiao, Kuang, Ming, Song, Tianqiang, Xiang, Bangde, Wang, Kui, Sun, Huichuan, Xu, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169746/
https://www.ncbi.nlm.nih.gov/pubmed/37180173
http://dx.doi.org/10.3389/fimmu.2023.1138355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169746/
https://www.ncbi.nlm.nih.gov/pubmed/37180173
http://dx.doi.org/10.3389/fimmu.2023.1138355

Ejemplares similares